» Articles » PMID: 27162159

MRI-guided Prostate Adaptive Radiotherapy - A Systematic Review

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2016 May 11
PMID 27162159
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Dose escalated radiotherapy improves outcomes for men with prostate cancer. A plateau for benefit from dose escalation using EBRT may not have been reached for some patients with higher risk disease. The use of increasingly conformal techniques, such as step and shoot IMRT or more recently VMAT, has allowed treatment intensification to be achieved whilst minimising associated increases in toxicity to surrounding normal structures. To support further safe dose escalation, the uncertainties in the treatment target position will need be minimised using optimal planning and image-guided radiotherapy (IGRT). In particular the increasing usage of profoundly hypo-fractionated stereotactic therapy is predicated on the ability to confidently direct treatment precisely to the intended target for the duration of each treatment. This article reviews published studies on the influences of varies types of motion on daily prostate position and how these may be mitigated to improve IGRT in future. In particular the role that MRI has played in the generation of data is discussed and the potential role of the MR-Linac in next-generation IGRT is discussed.

Citing Articles

Neurovascular bundle sparing in hypofractionated radiotherapy maintained with realistic treatment uncertainties.

Kwakernaak R, Brand V, Rojo-Santiago J, Froklage F, Hoogeman M, Habraken S Phys Imaging Radiat Oncol. 2025; 33:100714.

PMID: 39981525 PMC: 11840216. DOI: 10.1016/j.phro.2025.100714.


Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on margins.

Kusters J, Monshouwer R, Koopmans P, Wendling M, Brunenberg E, Kerkmeijer L Strahlenther Onkol. 2025; .

PMID: 39808200 DOI: 10.1007/s00066-024-02346-z.


Cone-Beam Computed Tomography (CBCT)-Based Online Adaptive Radiation Therapy (oART) for a Prostate Cancer Patient With Inflammatory Bowel Disease and Bilateral Total Hip Arthroplasty: A Case Report.

Webster M, Lemus O, Tanny S, Cummings M, Zheng D Cureus. 2024; 16(9):e68990.

PMID: 39385924 PMC: 11463887. DOI: 10.7759/cureus.68990.


Dosimetric evaluation of ultrafractionated dose escalation with simultaneous integrated boost to intraprostatic lesion using 1.5-Tesla MR-Linac in localized prostate cancer.

Onal C, Arslan G, Yavas C, Efe E, Yavas G Rep Pract Oncol Radiother. 2024; 29(1):10-20.

PMID: 39165591 PMC: 11333072. DOI: 10.5603/rpor.99358.


Effect of synthetic CT on dose-derived toxicity predictors for MR-only prostate radiotherapy.

Thomas C, Dregely I, Oksuz I, Urbano T, Greener T, King A BJR Open. 2024; 6(1):tzae014.

PMID: 38948455 PMC: 11213647. DOI: 10.1093/bjro/tzae014.